2seventy bio (MEX:TSVT) Net Income From Continuing Operations: MXN-137.0 Mil (TTM As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TSVT 2seventy bio Inc MEX:TSVT
9 GF Score
Price MXN170.00
View Full Analysis

What is 2seventy bio Net Income From Continuing Operations?

2seventy bio MEX:TSVT 9 Net Income From Continuing Operations is MXN-137.0 Mil as of Mar. 2025. GuruFocus rates MEX:TSVT with a GF Score™ of 9/100.

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. 2seventy bio's net income from continuing operations for the three months ended in Mar. 2025 was MXN9.9 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was MXN-137.0 Mil.

2seventy bio Net Income From Continuing Operations Historical Data

* Premium members only.

The historical data trend for 2seventy bio's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2seventy bio Net Income From Continuing Operations Chart

2seventy bio Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial -2,389.31 -5,994.46 -4,954.97 -3,693.09 -1,193.93

2seventy bio Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -874.18 455.79 -195.58 -407.10 9.86
MEX:TSVT
9GF Score
2seventy bio Inc MEX:TSVT
Net Income From Continuing Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

2seventy bio Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-137.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income From Continuing Operations of MXN-137.0 Mil mean?
2seventy bio (MEX:TSVT) has a Net Income From Continuing Operations of MXN-137.0 Mil as of Mar. 2025. The total net income from continuing operations as record on a company's cash-flow statement. View historical data for 2seventy bio and its competitors.
Is 2seventy bio's Net Income From Continuing Operations too high?
2seventy bio's current Net Income From Continuing Operations is MXN-137.0 Mil. Overall, 2seventy bio has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does 2seventy bio's Net Income From Continuing Operations compare to ALMS and TERN?
2seventy bio's Net Income From Continuing Operations of MXN-137.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income From Continuing Operations for a Biotechnology company?
A good Net Income From Continuing Operations depends on the Biotechnology industry context. However, Net Income From Continuing Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income From Continuing Operations mean?
A high Net Income From Continuing Operations can signal that a stock is expensive relative to its fundamentals. The total net income from continuing operations as record on a company's cash-flow statement. View historical data for 2seventy bio and its competitors. 2seventy bio's current Net Income From Continuing Operations is MXN-137.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 2seventy bio stock overvalued right now?
2seventy bio (MEX:TSVT) has a current Net Income From Continuing Operations of MXN-137.0 Mil. The current Net Income From Continuing Operations is MXN-137.0 Mil. 2seventy bio's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income From Continuing Operations calculated?
Net Income From Continuing Operations is calculated from a company's financial statements. For 2seventy bio (MEX:TSVT), the current Net Income From Continuing Operations is MXN-137.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

2seventy bio Business Description

Address 60 Binney Street, Cambridge, MA, USA, 02142
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.
9GF Score

Get the complete analysis for MEX:TSVT

Net Income From Continuing Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price